26 results
424B5
AXSM
Axsome Therapeutics Inc
28 Jun 23
Prospectus supplement for primary offering
8:16pm
, investment management, investment research, principal investment, hedging, financing and brokerage activities. Some of the underwriters and certain … into hedging transactions with broker-dealers and the broker-dealers may engage in short sales of the securities in the course of hedging the positions
424B5
AXSM
Axsome Therapeutics Inc
27 Jun 23
Prospectus supplement for primary offering
8:51pm
trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing … through registered or licensed brokers or dealers.
We may enter into hedging transactions with broker-dealers and the broker-dealers may engage in short
S-3ASR
AXSM
Axsome Therapeutics Inc
2 Dec 22
Automatic shelf registration
5:27pm
or dealers.
We may enter into hedging transactions with broker-dealers and the broker-dealers may engage in short sales of the securities in the course … of hedging the positions they assume with us, including, without limitation, in connection with distributions of the securities by those broker-dealers. We
424B5
klaznpa
19 Aug 22
Prospectus supplement for primary offering
9:35pm
424B5
71bxutqk
1 Mar 22
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
yabym0axc
13 Jan 20
Agreement accelerates ongoing clinical development of AXS-12 (reboxetine) in narcolepsy
8:39am
424B5
lxy9udwp5qb25ktu629t
20 Dec 19
Prospectus supplement for primary offering
12:00am
424B5
2nt421x0105batte
18 Dec 19
Prospectus supplement for primary offering
5:41pm
S-3ASR
px3sjvzqr
5 Dec 19
Automatic shelf registration
5:03pm
424B5
f6siwbp0z yyeok8xqx
9 May 19
Prospectus supplement for primary offering
4:59pm